TrialDiabetologia2012
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: a randomised double-blind placebo-controlled study.
B Eliasson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this paperpooled ittrialcites it